Ian Krop

Ian Krop, MD, PhD, is a Professor of Internal Medicine (Medical Oncology) at Yale School of Medicine and holds leadership roles at Yale Cancer Center, including Associate Director for Clinical Sciences, Director of the Clinical Trials Office, and Chief Clinical Research Officer. He specializes in breast cancer treatment, particularly HER2-positive malignancies, and leads clinical trials exploring novel therapies, genomic tools, and patient-reported outcomes. His work focuses on overcoming drug resistance, managing brain metastases, and improving outcomes for HER2-positive cancers.

Dr. Krop earned his MD and PhD in Biochemistry from Johns Hopkins University. He previously served at Dana-Farber Cancer Institute and Harvard Medical School. His research has been funded by the NCI, Susan G. Komen, and the Breast Cancer Research Foundation. Notable achievements include advancing therapies like trastuzumab deruxtecan and identifying biomarkers for treatment response.

He received the 2025 Gianni Bonadonna Breast Cancer Award, recognizing his contributions to clinical oncology. Dr. Krop’s team investigates strategies to combat residual disease and enhance patient care through translational research and clinical innovation.